DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $13,323,000 | +11.3% | 2,562,104 | 0.0% | 1.48% | +38.0% |
Q3 2016 | $11,965,000 | +18.5% | 2,562,104 | 0.0% | 1.07% | +9.3% |
Q2 2016 | $10,095,000 | +27.1% | 2,562,104 | 0.0% | 0.98% | +27.9% |
Q1 2016 | $7,943,000 | -32.2% | 2,562,104 | 0.0% | 0.77% | +6.5% |
Q4 2015 | $11,709,000 | +5.2% | 2,562,104 | +8.5% | 0.72% | +16.3% |
Q3 2015 | $11,126,000 | -32.9% | 2,362,104 | +1.9% | 0.62% | -30.6% |
Q2 2015 | $16,593,000 | -8.0% | 2,317,489 | +8.8% | 0.89% | -36.6% |
Q1 2015 | $18,045,000 | -47.8% | 2,130,477 | -42.6% | 1.41% | -6.5% |
Q4 2014 | $34,576,000 | +127.5% | 3,713,754 | +103.6% | 1.50% | -5.6% |
Q3 2014 | $15,197,000 | -64.0% | 1,824,377 | -50.0% | 1.59% | -23.3% |
Q2 2014 | $42,180,000 | +99.2% | 3,648,754 | +118.5% | 2.08% | +1.2% |
Q1 2014 | $21,173,000 | +124.5% | 1,669,777 | +91.6% | 2.05% | +64.9% |
Q4 2013 | $9,431,000 | -1.3% | 871,598 | +13.0% | 1.24% | -26.7% |
Q3 2013 | $9,552,000 | -7.7% | 771,598 | -0.4% | 1.70% | -16.2% |
Q2 2013 | $10,346,000 | – | 775,000 | – | 2.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |